glycine has been researched along with African Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Wilke, AC | 1 |
| Doebele, C | 1 |
| Zindel, A | 1 |
| Lee, KS | 1 |
| Rieke, SA | 1 |
| Ceribelli, M | 1 |
| Comoglio, F | 1 |
| Phelan, JD | 1 |
| Wang, JQ | 1 |
| Pikman, Y | 1 |
| Jahn, D | 1 |
| Häupl, B | 1 |
| Schneider, C | 1 |
| Scheich, S | 1 |
| Tosto, FA | 1 |
| Bohnenberger, H | 1 |
| Stauder, P | 1 |
| Schnütgen, F | 1 |
| Slabicki, M | 1 |
| Coulibaly, ZA | 1 |
| Wolf, S | 1 |
| Bojarczuk, K | 1 |
| Chapuy, B | 1 |
| Brandts, CH | 1 |
| Stroebel, P | 1 |
| Lewis, CA | 1 |
| Engelke, M | 1 |
| Xu, X | 1 |
| Kim, H | 1 |
| Dang, TH | 1 |
| Schmitz, R | 1 |
| Hodson, DJ | 1 |
| Stegmaier, K | 1 |
| Urlaub, H | 1 |
| Serve, H | 1 |
| Schmitt, CA | 1 |
| Kreuz, F | 1 |
| Knittel, G | 1 |
| Rabinowitz, JD | 1 |
| Reinhardt, HC | 1 |
| Vander Heiden, MG | 1 |
| Thomas, C | 1 |
| Staudt, LM | 1 |
| Zenz, T | 1 |
| Oellerich, T | 1 |
| Lee, SP | 1 |
| Brooks, JM | 1 |
| Al-Jarrah, H | 1 |
| Thomas, WA | 1 |
| Haigh, TA | 1 |
| Taylor, GS | 1 |
| Humme, S | 1 |
| Schepers, A | 1 |
| Hammerschmidt, W | 1 |
| Yates, JL | 1 |
| Rickinson, AB | 1 |
| Blake, NW | 1 |
| Tong, X | 1 |
| Yalamanchili, R | 1 |
| Harada, S | 1 |
| Kieff, E | 1 |
| O'Driscoll, M | 1 |
| Macpherson, P | 1 |
| Xu, YZ | 1 |
| Karran, P | 1 |
| Kondrat'eva, NA | 1 |
| Dobrynin, IaV | 1 |
| Merkulov, MF | 1 |
| Fell, D | 1 |
| Selhub, J | 1 |
| Reem, GH | 1 |
7 other studies available for glycine and African Lymphoma
| Article | Year |
|---|---|
SHMT2 inhibition disrupts the TCF3 transcriptional survival program in Burkitt lymphoma.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Burkitt Lymphoma; Cell Line, Tumor; Cell Surv | 2022 |
CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
Topics: Alanine; Amino Acid Sequence; Burkitt Lymphoma; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Epstei | 2004 |
The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
Topics: Amino Acid Sequence; Antigens, Viral; Arginine; Base Sequence; Binding Sites; Burkitt Lymphoma; Cell | 1994 |
The cytotoxicity of DNA carboxymethylation and methylation by the model carboxymethylating agent azaserine in human cells.
Topics: Adenine; Alkylating Agents; Azaserine; Azo Compounds; Burkitt Lymphoma; Carcinogens; DNA Adducts; DN | 1999 |
[Biological properties of L-asparaginase preparations from E. coli in cell cultures].
Topics: Asparaginase; Burkitt Lymphoma; Cell Line; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Stabili | 1978 |
Disruption of thymidylate synthesis and glycine-serine interconversion by L-methionine and L-homocystine in Raji cells.
Topics: Amino Acids; Burkitt Lymphoma; Glycine; Glycine Hydroxymethyltransferase; Homocystine; Humans; Methi | 1990 |
Pharmacologic regulation of the early steps of purine biosynthesis in Burkitt lymphoma cells and in Ehrlich ascites tumor cells.
Topics: Adenosine Monophosphate; Allopurinol; Amines; Ammonia; Animals; Burkitt Lymphoma; Carbon Radioisotop | 1974 |